Related Experiment Videos

Transscleral diode laser in the treatment of retinopathy of prematurity

A R Davis1, H Jackson, D Trew

  • 1King's College Hospital, London, UK.

Eye (London, England)
|February 29, 2000
PubMed

Insights

Contact transscleral diode laser (TSDL) effectively treated threshold retinopathy of prematurity (ROP) in most infants. This laser photocoagulation offers a promising alternative to cryotherapy for ROP management.

Area of Science:

  • Ophthalmology
  • Neonatal care

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of blindness in premature infants.
  • Threshold ROP requires timely intervention to prevent severe visual impairment.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of contact transscleral diode laser (TSDL) photocoagulation for threshold retinopathy of prematurity (ROP).

Main Methods:

  • TSDL was applied to 14 eyes of 8 infants diagnosed with threshold ROP.
  • The study included infants with a median post-conceptual age of 26+1 weeks and median birthweight of 835g.
  • Follow-up ranged from 9 to 41 weeks.

Main Results:

  • Successful regression of ROP with good anatomical outcome was observed in 11 eyes (79%) after a single TSDL treatment.
  • Unfavorable responses, including traction retinal detachment and fibrotic bands, occurred in 3 eyes (21%).
  • No significant complications directly related to the laser treatment were reported.

Conclusions:

  • Contact transscleral diode laser (TSDL) photocoagulation demonstrates effectiveness in treating threshold ROP.
  • TSDL presents a technically straightforward and viable alternative to traditional cryotherapy for ROP management.
Abstract

Related Concept Videos